Effective July 1, 2017, Maryland Medicaid will provide reimbursement for residential substance use disorder treatment for certain Medicaid-eligible individuals aged 21-64, as designated by the American Society of Addiction Medicine.
The Centers for Medicare and Medicaid Services granted the Department the authority to reimburse for therapeutic services associated with residential substance use disorder treatment levels of care through its 1115 HealthChoice Waiver Renewal.
>Sign up to receive Provider Alerts: firstname.lastname@example.org
Prior to applying to become a Maryland Medicaid Residential Substance Use Disorder Treatment provider, please review the associated provider and service requirements:
*The Notice of Proposed Action for COMAR 10.09.06 will formally post in the Maryland Register on June 23, 2017. The formal comment period will be open for 30 days. Submit comments on the proposed regulations to email@example.com. Any comments submitted outside the 30-day formal comment period will be considered informal.
If you are interested in applying to become a Maryland Medicaid Residential Substance Use Disorder Treatment provider, please submit the provider application.
Residential Substance Use Disorder Treatment providers are required to attest to certain staff requirements. In cases where there are certain staffing challenges, Maryland Medicaid allows for a 90-day staffing grace period from July 1, 2017.
201 W. Preston Street, Baltimore, MD 21201-2399
(410) 767-6500 or 1-877-463-3464